Trials / Enrolling By Invitation
Enrolling By InvitationNCT07347379
Long-Term Clinical Outcomes Of Subjects Enrolled In The RxSight Light Adjustable Lens (LAL) And Light Delivery Device (LDD) New Enrollment Study
- Status
- Enrolling By Invitation
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (estimated)
- Sponsor
- RxSight, Inc. · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This is an observational, follow up study of subjects previously enrolled in the "RxSight Light Adjustable Lens (LAL) and Light Delivery Device (LDD) New Enrollment Study". The primary objective of this study is to collect long-term safety and effectiveness data on RxSight LAL and Control IOL in subjects previously implanted in the "RxSight Light Adjustable Lens (LAL) and Light Delivery Device (LDD) New Enrollment Study".
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Light Adjustable lens (LAL) and Light Delivery Device (LDD) | Experimental treatment group received Light adjustable lens with Light delivery Device treatments |
| DEVICE | Control IOL | Control treatment group received a Control IOL |
Timeline
- Start date
- 2025-11-13
- Primary completion
- 2026-06-01
- Completion
- 2026-09-01
- First posted
- 2026-01-16
- Last updated
- 2026-01-16
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT07347379. Inclusion in this directory is not an endorsement.